These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis. Corey KE, Schmitz SM, Shaheen NJ. Am J Gastroenterol; 2003 Nov; 98(11):2390-4. PubMed ID: 14638338 [Abstract] [Full Text] [Related]
17. New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy. DeMeester SR. Ann Thorac Surg; 2008 Feb; 85(2):S747-50. PubMed ID: 18222209 [No Abstract] [Full Text] [Related]
19. Barrett's adenocarcinoma 52 years after subtotal esophagectomy for pediatric peptic stricture. Dunn LJ, Robertson AG, Immanuel A, Griffin SM. Ann Thorac Surg; 2010 Feb; 89(2):604-6. PubMed ID: 20103354 [Abstract] [Full Text] [Related]
20. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Larghi A, Lightdale CJ, Ross AS, Fedi P, Hart J, Rotterdam H, Noffsinger A, Memeo L, Bhagat G, Waxman I. Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854 [Abstract] [Full Text] [Related] Page: [Next] [New Search]